Pharmaceutical Industry Library
Become an expert and trusted advisor in the rapidly changing industry of pharmaceuticals. Becker’s CPE Pharmaceutical Industry Library is the perfect solution to get up-to-speed quickly and efficiently – while earning 9.5 CPE credits. Learn about the pharmaceuticals industry, including key concepts, industry trends and challenges. With these courses, you will learn how to break down the complexities of the revenue recognition process and review unique pharmaceutical examples. You will also examine examples of financial statements and delve into the top companies in the pharmaceutical industry and their financial norms. Give yourself the tools to improve business decisions and mitigate risk by ensuring you become an expert in the pharmaceutical industry.
Internal accountants looking to deepen the industry expertise and value they bring. Consultants wanting to broaden their field of expertise for clients. And, auditors aiming to hone their banking specialization for those they serve.
Internal accountants looking to deepen the industry expertise and value they bring. Consultants wanting to broaden their field of expertise for clients. And, auditors aiming to hone their banking specialization for those they serve.
Internal accountants looking to deepen the industry expertise and value they bring. Consultants wanting to broaden their field of expertise for clients. And, auditors aiming to hone their banking specialization for those they serve.
- This 8-course, 9.5-credit Library takes you on an easy-to-follow journey with all the important pharmaceutical accounting topics in one place. Once the foundation is set, you will then deep dive into specific pharmaceutical issues.
- Our instructors don't just teach the industry, they live it. Bringing years of pharmaceutical accounting experience to the table, they know exactly what information is most relevant — and most valuable — to you.
- Get up-to-speed quickly and efficiently in a way that fits both your lifestyle and learning style. This Library includes 24/7 on demand access and includes multiple 1–2 credit hour courses.
- The Pharmaceutical Library will be available for 12 months after the purchase date.
- This 8-course, 9.5-credit Library takes you on an easy-to-follow journey with all the important pharmaceutical accounting topics in one place. Once the foundation is set, you will then deep dive into specific pharmaceutical issues.
- Our instructors don't just teach the industry, they live it. Bringing years of pharmaceutical accounting experience to the table, they know exactly what information is most relevant — and most valuable — to you.
- Get up-to-speed quickly and efficiently in a way that fits both your lifestyle and learning style. This Library includes 24/7 on demand access and includes multiple 1–2 credit hour courses.
- The Pharmaceutical Library will be available for 12 months after the purchase date.
- This 8-course, 9.5-credit Library takes you on an easy-to-follow journey with all the important pharmaceutical accounting topics in one place. Once the foundation is set, you will then deep dive into specific pharmaceutical issues.
- Our instructors don't just teach the industry, they live it. Bringing years of pharmaceutical accounting experience to the table, they know exactly what information is most relevant — and most valuable — to you.
- Get up-to-speed quickly and efficiently in a way that fits both your lifestyle and learning style. This Library includes 24/7 on demand access and includes multiple 1–2 credit hour courses.
- The Pharmaceutical Library will be available for 12 months after the purchase date.
Accounting and Finance Business Consultant, The Emperic Group LLC, CPA, MBA
Scott C. Larson has 30+ years of business experience in financial reporting, consolidating and analysis. Scott is a seasoned professional in a variety of industries, including pharmaceutical, manufacturing and healthcare information technology.
Accounting and Finance Business Consultant, The Emperic Group LLC, CPA, MBA
Scott C. Larson has 30+ years of business experience in financial reporting, consolidating and analysis. Scott is a seasoned professional in a variety of industries, including pharmaceutical, manufacturing and healthcare information technology.
Accounting and Finance Business Consultant, The Emperic Group LLC, CPA, MBA
Scott C. Larson has 30+ years of business experience in financial reporting, consolidating and analysis. Scott is a seasoned professional in a variety of industries, including pharmaceutical, manufacturing and healthcare information technology.
The pharmaceutical industry contributes over $500 billion in GDP annually and employs over 5.5 million people worldwide. Given the size and highly technical nature of the pharmaceutical industry, it’s imperative that professionals working within the industry have a solid knowledge base of the key components that encompass it. This course will provide just that. You will learn industry terminology and concepts so you can talk the talk and feel confident navigating within the industry.
Instructor: Scott Larson
CPE Credits: 1.5
The pharmaceutical industry contributes over $500 billion in GDP annually and employs over 5.5 million people worldwide. Given the size and highly technical nature of the pharmaceutical industry, it’s imperative that professionals working within the industry have a solid knowledge base of the key components that encompass it. This course will provide just that. You will learn industry terminology and concepts so you can talk the talk and feel confident navigating within the industry.
Instructor: Scott Larson
CPE Credits: 1.5
The pharmaceutical industry contributes over $500 billion in GDP annually and employs over 5.5 million people worldwide. Given the size and highly technical nature of the pharmaceutical industry, it’s imperative that professionals working within the industry have a solid knowledge base of the key components that encompass it. This course will provide just that. You will learn industry terminology and concepts so you can talk the talk and feel confident navigating within the industry.
Instructor: Scott Larson
CPE Credits: 1.5
Revenue recognition is a complex accounting topic. This course will break down the complexities of revenue recognition by examining each component of the process, as it applies to unique pharmaceutical examples. Specific attention will be given to the impact on various revenue streams commonly seen in the industry.
Instructor: Scott Larson
CPE Credits: 1.0
Revenue recognition is a complex accounting topic. This course will break down the complexities of revenue recognition by examining each component of the process, as it applies to unique pharmaceutical examples. Specific attention will be given to the impact on various revenue streams commonly seen in the industry.
Instructor: Scott Larson
CPE Credits: 1.0
Revenue recognition is a complex accounting topic. This course will break down the complexities of revenue recognition by examining each component of the process, as it applies to unique pharmaceutical examples. Specific attention will be given to the impact on various revenue streams commonly seen in the industry.
Instructor: Scott Larson
CPE Credits: 1.0
Analyzing financial statements is centered on the interrelationships of financial data and the ability to use this data to form conclusions. In this course, you will learn how to identify risks that are inherent in the financial statements and discover the tools that are used to analyze the statements. A keystone to any financial analysis is industry comparability. This course delves into the top companies represented in the pharmaceutical industry and their financial norms. You will explore excerpts from real financial statements and witness cutting-edge examples of financial analysis.
Instructor: Scott Larson
CPE Credits: 1.5
Analyzing financial statements is centered on the interrelationships of financial data and the ability to use this data to form conclusions. In this course, you will learn how to identify risks that are inherent in the financial statements and discover the tools that are used to analyze the statements. A keystone to any financial analysis is industry comparability. This course delves into the top companies represented in the pharmaceutical industry and their financial norms. You will explore excerpts from real financial statements and witness cutting-edge examples of financial analysis.
Instructor: Scott Larson
CPE Credits: 1.5
Analyzing financial statements is centered on the interrelationships of financial data and the ability to use this data to form conclusions. In this course, you will learn how to identify risks that are inherent in the financial statements and discover the tools that are used to analyze the statements. A keystone to any financial analysis is industry comparability. This course delves into the top companies represented in the pharmaceutical industry and their financial norms. You will explore excerpts from real financial statements and witness cutting-edge examples of financial analysis.
Instructor: Scott Larson
CPE Credits: 1.5
Pharmaceutical companies are known for their innovative research and development processes aimed at treating various diseases. The cost for R&D is substantive and the chances for success are small. To be successful, companies in the pharmaceutical industry must effectively manage expansions, patents, and new drugs and products. This course will explore the project life cycle from drug discovery to regulatory approval, and the creation of an internally-developed asset, by reviewing industry examples and applying the appropriate accounting treatment to costs at each stage of the process. We will then identify indicators of an asset impairment and the proper financial statement recognition.
Instructor: Scott Larson
CPE Credits: 1.0
Pharmaceutical companies are known for their innovative research and development processes aimed at treating various diseases. The cost for R&D is substantive and the chances for success are small. To be successful, companies in the pharmaceutical industry must effectively manage expansions, patents, and new drugs and products. This course will explore the project life cycle from drug discovery to regulatory approval, and the creation of an internally-developed asset, by reviewing industry examples and applying the appropriate accounting treatment to costs at each stage of the process. We will then identify indicators of an asset impairment and the proper financial statement recognition.
Instructor: Scott Larson
CPE Credits: 1.0
Pharmaceutical companies are known for their innovative research and development processes aimed at treating various diseases. The cost for R&D is substantive and the chances for success are small. To be successful, companies in the pharmaceutical industry must effectively manage expansions, patents, and new drugs and products. This course will explore the project life cycle from drug discovery to regulatory approval, and the creation of an internally-developed asset, by reviewing industry examples and applying the appropriate accounting treatment to costs at each stage of the process. We will then identify indicators of an asset impairment and the proper financial statement recognition.
Instructor: Scott Larson
CPE Credits: 1.0
Innovation in the pharmaceutical industry is linked to huge breakthroughs in healthcare. Intellectual property laws help protect the investments that companies make in these advancements. This course will explore the types of intellectual property that are found in the pharmaceutical industry as well as why these assets are valuable. We will delve into the laws associated with intellectual property and proper reporting of these assets in the financial statements.
Instructor: Scott Larson
CPE Credits: 1.0
Innovation in the pharmaceutical industry is linked to huge breakthroughs in healthcare. Intellectual property laws help protect the investments that companies make in these advancements. This course will explore the types of intellectual property that are found in the pharmaceutical industry as well as why these assets are valuable. We will delve into the laws associated with intellectual property and proper reporting of these assets in the financial statements.
Instructor: Scott Larson
CPE Credits: 1.0
Innovation in the pharmaceutical industry is linked to huge breakthroughs in healthcare. Intellectual property laws help protect the investments that companies make in these advancements. This course will explore the types of intellectual property that are found in the pharmaceutical industry as well as why these assets are valuable. We will delve into the laws associated with intellectual property and proper reporting of these assets in the financial statements.
Instructor: Scott Larson
CPE Credits: 1.0
The pharmaceutical industry is one of the most active industries in terms of business combinations, asset acquisitions, and divestitures. This course will provide you with industry-specific information by explaining the general concepts and definitions, demonstrating the strategy for these types of business transactions, and doing a deep dive into industry-specific examples that walk through the accounting treatment of each.
Instructor: Scott Larson
CPE Credits: 1.0
The pharmaceutical industry is one of the most active industries in terms of business combinations, asset acquisitions, and divestitures. This course will provide you with industry-specific information by explaining the general concepts and definitions, demonstrating the strategy for these types of business transactions, and doing a deep dive into industry-specific examples that walk through the accounting treatment of each.
Instructor: Scott Larson
CPE Credits: 1.0
The pharmaceutical industry is one of the most active industries in terms of business combinations, asset acquisitions, and divestitures. This course will provide you with industry-specific information by explaining the general concepts and definitions, demonstrating the strategy for these types of business transactions, and doing a deep dive into industry-specific examples that walk through the accounting treatment of each.
Instructor: Scott Larson
CPE Credits: 1.0
Environmental, social and governance (ESG) reporting is more relevant now than ever before. Learn how the pharmaceutical industry is responding to the evolving ESG reporting requirements and what industry leaders are doing to prepare for the road ahead. We will review real-life examples of ESG reports, examine best practices and discuss proactive industry-specific initiatives that are leading the way.
Instructor: Scott Larson
CPE Credits: 1.0
Environmental, social and governance (ESG) reporting is more relevant now than ever before. Learn how the pharmaceutical industry is responding to the evolving ESG reporting requirements and what industry leaders are doing to prepare for the road ahead. We will review real-life examples of ESG reports, examine best practices and discuss proactive industry-specific initiatives that are leading the way.
Instructor: Scott Larson
CPE Credits: 1.0
Environmental, social and governance (ESG) reporting is more relevant now than ever before. Learn how the pharmaceutical industry is responding to the evolving ESG reporting requirements and what industry leaders are doing to prepare for the road ahead. We will review real-life examples of ESG reports, examine best practices and discuss proactive industry-specific initiatives that are leading the way.
Instructor: Scott Larson
CPE Credits: 1.0
In conjunction with the Mapping the Industry course, Key Tax Concepts and Challenges is an overview providing the definitions and tools needed to understand the tax issues facing the pharmaceutical industry. This course covers federal tax issues, including the Inflation Reduction Act, the Organisation for Economic Co-operation and Development (OECD) Pillar Two Model Rules, and specific state tax research and development credits that are particularly relevant to pharmaceutical companies.
Instructor: Mary Walsh
CPE Credits: 1.5
In conjunction with the Mapping the Industry course, Key Tax Concepts and Challenges is an overview providing the definitions and tools needed to understand the tax issues facing the pharmaceutical industry. This course covers federal tax issues, including the Inflation Reduction Act, the Organisation for Economic Co-operation and Development (OECD) Pillar Two Model Rules, and specific state tax research and development credits that are particularly relevant to pharmaceutical companies.
Instructor: Mary Walsh
CPE Credits: 1.5
In conjunction with the Mapping the Industry course, Key Tax Concepts and Challenges is an overview providing the definitions and tools needed to understand the tax issues facing the pharmaceutical industry. This course covers federal tax issues, including the Inflation Reduction Act, the Organisation for Economic Co-operation and Development (OECD) Pillar Two Model Rules, and specific state tax research and development credits that are particularly relevant to pharmaceutical companies.
Instructor: Mary Walsh
CPE Credits: 1.5
- 60+ years supporting accounting professionals looking to continue their education
- Partner of 2,900+ top accounting firms, corporations, alliances and government agencies
- 96% of Becker customers say all their CPE needs are met
- 60+ years supporting accounting professionals looking to continue their education
- Partner of 2,900+ top accounting firms, corporations, alliances and government agencies
- 96% of Becker customers say all their CPE needs are met
- 60+ years supporting accounting professionals looking to continue their education
- Partner of 2,900+ top accounting firms, corporations, alliances and government agencies
- 96% of Becker customers say all their CPE needs are met
You’re in the right place. Discover the impact you can have in other complex, rapidly changing industries. Each Library includes everything you need to master the skills your clients or business need most.
You’re in the right place. Discover the impact you can have in other complex, rapidly changing industries. Each Library includes everything you need to master the skills your clients or business need most.
You’re in the right place. Discover the impact you can have in other complex, rapidly changing industries. Each Library includes everything you need to master the skills your clients or business need most.
A Becker Professional Education is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org
Becker Professional Education Sponsor I.D. Numbers NASBA: 107294, New York: 002087, New Jersey: 20CE00226700, Texas: 009580, Ohio: CPE.186, Illinois 158.002405, Pennsylvania: PX177823